Matches in Wikidata for { <http://www.wikidata.org/entity/Q97652683> ?p ?o ?g. }
- Q97652683 description "2020 nî lūn-bûn" @default.
- Q97652683 description "2020年の論文" @default.
- Q97652683 description "2020年学术文章" @default.
- Q97652683 description "2020年学术文章" @default.
- Q97652683 description "2020年学术文章" @default.
- Q97652683 description "2020年学术文章" @default.
- Q97652683 description "2020年学术文章" @default.
- Q97652683 description "2020年学术文章" @default.
- Q97652683 description "2020年學術文章" @default.
- Q97652683 description "2020年學術文章" @default.
- Q97652683 description "2020年學術文章" @default.
- Q97652683 description "2020年學術文章" @default.
- Q97652683 description "2020年學術文章" @default.
- Q97652683 description "2020년 논문" @default.
- Q97652683 description "article científic" @default.
- Q97652683 description "article scientific" @default.
- Q97652683 description "article scientifique" @default.
- Q97652683 description "articol științific" @default.
- Q97652683 description "articolo scientifico" @default.
- Q97652683 description "artigo científico" @default.
- Q97652683 description "artigo científico" @default.
- Q97652683 description "artigo científico" @default.
- Q97652683 description "artikel ilmiah" @default.
- Q97652683 description "artikull shkencor" @default.
- Q97652683 description "artikulong pang-agham" @default.
- Q97652683 description "artykuł naukowy" @default.
- Q97652683 description "artículo científico publicado en 2020" @default.
- Q97652683 description "artículu científicu" @default.
- Q97652683 description "bilimsel makale" @default.
- Q97652683 description "bài báo khoa học" @default.
- Q97652683 description "naučni članak" @default.
- Q97652683 description "scienca artikolo" @default.
- Q97652683 description "scientific article published on 22 July 2020" @default.
- Q97652683 description "scientific article published on 22 July 2020" @default.
- Q97652683 description "scientific article published on 22 July 2020" @default.
- Q97652683 description "teaduslik artikkel" @default.
- Q97652683 description "tieteellinen artikkeli" @default.
- Q97652683 description "tudományos cikk" @default.
- Q97652683 description "vedecký článok" @default.
- Q97652683 description "vetenskaplig artikel" @default.
- Q97652683 description "videnskabelig artikel udgivet 22. juli 2020" @default.
- Q97652683 description "vitenskapelig artikkel" @default.
- Q97652683 description "vitskapeleg artikkel" @default.
- Q97652683 description "vědecký článek" @default.
- Q97652683 description "wetenschappelijk artikel" @default.
- Q97652683 description "wissenschaftlicher Artikel" @default.
- Q97652683 description "επιστημονικό άρθρο" @default.
- Q97652683 description "мақолаи илмӣ" @default.
- Q97652683 description "наукова стаття, опублікована в липні 2020" @default.
- Q97652683 description "научна статия" @default.
- Q97652683 description "научная статья" @default.
- Q97652683 description "научни чланак" @default.
- Q97652683 description "научни чланак" @default.
- Q97652683 description "מאמר מדעי" @default.
- Q97652683 description "مقالة علمية نشرت في 22 يوليو 2020" @default.
- Q97652683 description "২২ জুলাই ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q97652683 description "บทความทางวิทยาศาสตร์" @default.
- Q97652683 description "სამეცნიერო სტატია" @default.
- Q97652683 name "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive" @default.
- Q97652683 name "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive" @default.
- Q97652683 type Item @default.
- Q97652683 label "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive" @default.
- Q97652683 label "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive" @default.
- Q97652683 prefLabel "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive" @default.
- Q97652683 prefLabel "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive" @default.
- Q97652683 P1433 Q97652683-AE2AEC17-F0A3-4C27-A7CA-4FC892CB2639 @default.
- Q97652683 P1476 Q97652683-F4E800F5-7C14-42F9-8D6B-82EBF8970912 @default.
- Q97652683 P2093 Q97652683-10647D6C-878D-430D-9665-C5FD18BF8F96 @default.
- Q97652683 P2093 Q97652683-19416872-D4BF-480F-A395-DAFA75E2672E @default.
- Q97652683 P2093 Q97652683-1C3C9C21-4C0D-4546-A62C-FA75EFA08619 @default.
- Q97652683 P2093 Q97652683-2C7D65D0-EA97-4051-917F-83F53D2DB0D8 @default.
- Q97652683 P2093 Q97652683-605592C0-FEA4-45AF-9464-1F5A539DA7D7 @default.
- Q97652683 P2093 Q97652683-7B37BF1D-0A86-4A02-82A8-95B534613090 @default.
- Q97652683 P2093 Q97652683-7E8BF45D-DE2E-4FA0-AD50-E4B15D21594E @default.
- Q97652683 P2093 Q97652683-8D64175E-609A-4092-96EF-37082BAE06EB @default.
- Q97652683 P2093 Q97652683-927167F5-C5BE-4C80-B1A8-47E8DF5F606F @default.
- Q97652683 P2093 Q97652683-943BF647-47CC-45F4-8713-933FD8B7086A @default.
- Q97652683 P2093 Q97652683-C4E88897-D7E8-496F-81C2-B69365D25EE8 @default.
- Q97652683 P2093 Q97652683-FBAA650D-2D23-4421-B33B-CC8EFCDB463A @default.
- Q97652683 P2093 Q97652683-FC24F1B3-AFCA-4AAA-814A-183B5C664CC6 @default.
- Q97652683 P275 Q97652683-9425a715-4e9d-4432-b46e-34d133d18c27 @default.
- Q97652683 P304 Q97652683-424E5D62-B832-4AAB-82BB-3AA37B7FF0C7 @default.
- Q97652683 P31 Q97652683-917612BF-013E-4345-A41A-F96569EE5F5E @default.
- Q97652683 P356 Q97652683-388574BC-9ACE-454F-96C2-0681A4E66B95 @default.
- Q97652683 P433 Q97652683-E25B1288-81B8-439B-8D26-94245E4A064A @default.
- Q97652683 P478 Q97652683-1E287F7D-AC29-45F6-9589-943ED09F2C66 @default.
- Q97652683 P50 Q97652683-7D9F27FC-3B9A-4891-9C32-30F9F9EF2AAA @default.
- Q97652683 P577 Q97652683-89B2D359-3578-4BC0-B605-89BAC0D4B9EA @default.
- Q97652683 P6216 Q97652683-8fa16583-9dae-40a4-b3c3-1ad586e4897d @default.
- Q97652683 P698 Q97652683-AF941A93-E914-49D4-B2E3-D11D5527B1CD @default.
- Q97652683 P356 BMJOPEN-2020-038856 @default.
- Q97652683 P698 32699168 @default.
- Q97652683 P1433 Q17003470 @default.
- Q97652683 P1476 "Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI)" @default.
- Q97652683 P2093 "Alexander J Needham" @default.
- Q97652683 P2093 "Andrew Weimken" @default.
- Q97652683 P2093 "Ari Manuel" @default.
- Q97652683 P2093 "Daniel J Cuthbertson" @default.
- Q97652683 P2093 "Graham J Kemp" @default.
- Q97652683 P2093 "John Ph Wilding" @default.